"10.1371_journal.pone.0013856","plos one","2010-11-09T00:00:00Z","Romain Micol; Ayden Tajahmady; Olivier Lortholary; Suna Balkan; Catherine Quillet; Jean-Philippe Dousset; Hak Chanroeun; Yoann Madec; Arnaud Fontanet; Yazdan Yazdanpanah","Unité d'Epidémiologie des Maladies Emergentes, Institut Pasteur, Paris, France; Laboratoire de Virologie, Université Paris Descartes EA 36-20, Hôpital Necker-Enfants Malades, Paris, France; Mission nationale d'expertise et d'audit hospitaliers, Paris, France; Institut Pasteur, Centre National de Référence Mycologie et Antifongiques, Unité de Mycologie Moléculaire, CNRS URA3012, Paris, France; Université Paris Descartes, Service des Maladies Infectieuses et Tropicales, Centre d'Infectiologie Necker-Pasteur, Hôpital Necker-Enfants Malades, Paris, France; Médecins Sans Frontières, Paris, France; Médecins du Monde, Hopital Kosamak, Phnom Penh, Cambodia; Service des Maladies Infectieuses, Hopital Calmette, Phnom Penh, Cambodia; Avenir-ATIP Unit, INSERM U995, Paris, France; Service Universitaire des Maladies Infectieuses et du Voyageur, CH Tourcoing, Faculté de Médecine de Lille, Lille, France","Conceived and designed the experiments: RM AT OL SB JPD HC AF YY. Analyzed the data: RM AT OL SB YY. Contributed reagents/materials/analysis tools: RM CQ JPD YM. Wrote the paper: RM AT OL SB CQ JPD HC YM AF YY.","Y. Yazdanpanah has received travel grants, honoraria for presentation at workshops and consultancy honoraria from Bristol-Myers Squibb, Gilead, Glaxo-SmithKline, Merck, Pfizer, Roche and Tibotec. O. Lortholary is a member of the speaker's bureau of Pfizer, MSD, Astellas, Schering Plough and Gilead Sciences and consultant for Astellas. R. Micol has received travel grants from Pfizer. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.","2010","11","Romain Micol","RM",10,TRUE,8,NA,5,10,TRUE,TRUE,FALSE,0,NA,FALSE
